We, the G7 Foreign Ministers of Canada, France, Germany, Italy, Japan, the United Kingdom and the United States of America, and the High Representative of the Union European Union, have approved the following action plan:
Much has already been achieved through our efforts to end the COVID-19 pandemic in 2022, with the global supply of vaccines now accelerating rapidly. However, there remain significant gaps in the global response to the current health crisis. Challenges remain to ensure fairness in this COVID-19 pandemic and preparedness for a future pandemic. As the G7, we have a particular responsibility to work with implementing countries and economies to help close these gaps. Given the widespread repercussions of the pandemic, foreign ministers have a crucial role to play in ensuring that comprehensive, cross-cutting and rapid action is taken.
Our contribution as foreign ministers to the overall G7 global health engagement in 2022 will focus on jointly closing gaps in the global COVID-19 vaccination campaign, including in critical contexts of the ‘last mile’ and focusing on vulnerable groups, broadening focus and support. for frontline health workers and the necessary equipment. In line with other G7 initiatives, we will work with countries and the international community to begin planning for the ongoing COVID-19 response for 2023 and beyond to help build political commitment for preparedness for the future. .
This effort aligns with the WHO Global Immunization Strategy and the commitment made by the G20 at the Leaders’ Summit in Rome in October 2021. To this end, we commit to:
• Continue to accelerate our efforts to ensure equitable and rapid global distribution of safe, effective, quality-assured and affordable vaccines as well as access to complementary diagnostics, treatments and other essential health products according to the needs of country in:
o Help finance and support, by all means, the efforts of ACT-A and its COVAX platform, particularly in low- and middle-income countries. The G7 has already provided and pledged $18.33 billion for ACT-A, of which $12.36 billion goes to the COVAX vaccine pillar, including GAVI, CEPI, WHO and UNICEF.
o When necessary and available, share additional doses of safe and effective vaccines, without any political strings attached, and use responsible practices in vaccine donations. The G7 has already donated 1.18 billion doses and stands ready to share additional doses, depending on country needs and capacities and the need for an optimal global allocation of vaccines (purchased by COVAX directly or through donations).
• Coordinate closely with manufacturers, COVAX, regional organizations and beneficiary countries and economies at all levels to support effective donor coordination efforts, optimize the pace of production and further improve the sharing process, better align lead times country needs and capabilities and address issues such as shelf life and to increase transparency, visibility and timing of planned deliveries.
• Work with governments, the COVID-19 Vaccine Delivery Partnership and other relevant stakeholders to support 115 countries in need, especially LICs, with $3.95 billion to address logistical, planning and delivery challenges. human resources on the “last mile” to ensure that vaccines become real vaccinations, in particular by:
o Support countries with syringes and other ancillary equipment;
o Provide evidence-based training on vaccine safety and effectiveness; and building the capacity of frontline health and care workers, expanding the frontline health workforce;
o Build trust in public institutions and tackle misinformation and disinformation on the ground by engaging with communities and conducting tailored information campaigns, based on scientific and factual evidence;
o Improved logistics through public-private partnerships (cold chains);
o Improve coordination of concrete actions on the ground between donors and implementing agencies to avoid duplication and create synergies between different activities, guided by WHO and other relevant multilateral actors involved, if applicable;
o Integrate measures into strengthened health systems to ensure that the administration of the COVID-19 vaccine does not weaken other essential health measures, but rather strengthens national immunization systems;
o Support national and subnational campaigns towards the 70% target, prioritizing coverage among health and frontline workers, older people and immunocompromised people.
• Leave no one behind in our global immunization campaign with a particular focus on historically marginalized and vulnerable groups, especially refugees, rural communities and women and girls, especially those living in crisis or in difficult situations. humanitarian contexts, and calling for the full operationalization of the COVAX Humanitarian Buffer, a valuable last resort measure to reach the most vulnerable communities and humanitarian situations.
• Protect frontline health workers and sustainably strengthen national health systems, for example by supporting detection and surveillance capacities at all levels.
MANUFACTURING OF VACCINES
• Increase sustainable local and regional production capacities in developing countries, through partnerships for voluntary technology transfers on mutually agreed terms and other relevant forms of support, with a focus on supporting the long-term sustainable capacity building for safe, effective and quality-assured COVID-19 vaccines, as well as broader vaccines and critical medical needs such as antivirals, allowing us to be flexible in responding to this pandemic and those to come.
• We therefore commit to supporting diversified global vaccine production by supporting the capacities of low- and middle-income countries through the sharing of knowledge, expertise and financing.
We will coordinate closely with other like-minded partners, international organizations and the United Nations as well as multilateral and regional initiatives to unite our efforts. The G7 Foreign Ministers recognize that it is essential to respond to the COVID-19 pandemic and, in parallel, to strengthen the capacities and architecture of global health security for the future.